Extracts exhibit health benefits
September 30, 2008
by Jeff Gelski
Extracts from FutureCeuticals, Inc., Momence, Ill., exhibited health benefits in studies conducted at the FutureCeuticals laboratories by Dr. Zbigniew Pietrzkowski, vice-president of research and development.
VitaGranate, a standardized pomegranate extract, was found to be an activator of the heart-health influencing enzyme Paraoxonase 1 (PON1) in an ex vivo study. Study results found VitaGranate stimulated PON1 in human serum by as much as 47%.
VitaBlue, a standardized blueberry extract, was shown to inhibit the Angiotensin Converting Enzyme (ACE) in vitro up to 98% at a concentration of 0.3%. High levels of this enzyme are associated with an increased risk of cardiovascular health concerns.
CranForte, a standardized cranberry and grape seed extract blend, was shown to inhibit low-densisty lipoprotein (L.D.L.) cholesterol in an ex vivo study.
For more information, visit www.futureceuticals.com.
This article can also be found in the digital edition of Food Business News, September 30, 2008, starting on Page 53. Click
to search that archive.